Opportunity Information: Apply for PAR 25 274
The National Institutes of Health, through the National Center for Complementary and Integrative Health (NCCIH), is offering the PAR-25-274 funding opportunity to support feasibility clinical trials of complementary and integrative health approaches that use physical and/or psychological therapeutic inputs, commonly referred to as mind and body interventions. The purpose is not to fund a full-scale efficacy or effectiveness trial right away, but to generate the specific early clinical evidence needed to properly design and justify a later, larger and more definitive study that fits within NCCIH priorities. In practical terms, this mechanism is meant to reduce uncertainty before investing in a major clinical trial by funding the kind of groundwork that makes a subsequent trial more rigorous, credible, and likely to succeed.
This Notice of Funding Opportunity focuses on conditions that NCCIH has identified as high-priority research topics. Applicants are expected to be explicit about what the eventual follow-on clinical trial will be (for example, an efficacy trial, effectiveness study, pragmatic trial, or dissemination and implementation trial) and to show why the proposed R34 feasibility work is scientifically necessary to plan that next step. Reviewers will be looking for a clear line connecting the feasibility trial to the future full-scale trial, including what design decisions the R34 data will support and how those decisions matter for public health impact. NCCIH emphasizes that the subsequent larger trial should have a realistic chance to meaningfully affect health outcomes at a population level, not just produce incremental or highly localized insights.
The R34 feasibility trial can be used to address several common problems that prevent a larger study from being ready. Examples named in the announcement include testing feasibility and acceptability when an intervention has little or no published clinical trial data, tailoring or adapting an intervention's content or structure for a particular population or setting, and refining key intervention parameters such as frequency, dose, intensity, or duration. It also supports practical trial-planning questions like whether recruitment strategies will work, whether retention will be adequate, whether outcome and data-collection procedures are workable, and whether multi-component or protocolized interventions can be delivered consistently across staff or sites. Another emphasized area is control group design, including whether control conditions are acceptable to participants and whether adherence and engagement are realistic, since weak control conditions can undermine the interpretability of later trials.
A notable feature of this NOFO is the requirement for a Plan for Enhancing Diverse Perspectives (PEDP). While the specific contents will follow NIH guidance, the intent is to ensure the research team, participant populations, study settings, and/or conceptual approaches reflect diversity in ways that strengthen the science and improve relevance and generalizability. NCCIH also encourages applicants to contact the appropriate NCCIH Scientific/Research contact before submission, which signals that early alignment with NCCIH priorities and expectations is important and may help applicants avoid proposing studies that do not fit the institute's mission or the intent of this mechanism.
Eligibility is broad and includes many types of U.S.-based organizations and governmental entities, such as state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The NOFO also explicitly highlights additional eligible categories such as Historically Black Colleges and Universities, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions, as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
Foreign organizations are not eligible to apply as applicants, and non-U.S. components of U.S. organizations are also not eligible. However, foreign components are allowed as defined by the NIH Grants Policy Statement, meaning a U.S. applicant may be able to include certain justified international elements (for example, specific expertise, resources, or populations) if they meet NIH rules and are well supported scientifically and administratively. The opportunity is categorized as a discretionary grant in the health area, associated with CFDA number 93.213. The funding opportunity was created on 2024-11-21, and the listed original closing date is 2026-11-17. The announcement does not provide an award ceiling or expected number of awards in the provided text, so applicants would need to consult the full NOFO for budget limits, project period constraints, and any institute-specific caps or expectations.Apply for PAR 25 274
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
- This funding opportunity was created on 2024-11-21.
- Applicants must submit their applications by 2026-11-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Performing Arts Global Exchange, FY 2026
Previous opportunity: USAID Inclusive Political Outreach
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 25 274
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 25 274) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required) Apply for RFA RM 24 008 Funding Number: RFA RM 24 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 24 076 Funding Number: RFA AI 24 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) Apply for RFA HL 26 017 Funding Number: RFA HL 26 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) Apply for RFA HL 26 016 Funding Number: RFA HL 26 016 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) Apply for PAR 25 281 Funding Number: PAR 25 281 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) Apply for RFA HL 26 020 Funding Number: RFA HL 26 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 25 226 Funding Number: PAR 25 226 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) Apply for PAR 25 282 Funding Number: PAR 25 282 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) Apply for RFA HL 26 018 Funding Number: RFA HL 26 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) Apply for PAR 25 291 Funding Number: PAR 25 291 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) Apply for PAR 25 290 Funding Number: PAR 25 290 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ukraine Mental Health Initiative for National Development Activity Apply for 72012125RFA00002 Funding Number: 72012125RFA00002 Agency: Ukraine USAID-Kiev Category: Health Funding Amount: $50,000,000 |
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 25 158 Funding Number: PAR 25 158 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required) Apply for PAR 25 289 Funding Number: PAR 25 289 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) Apply for PAR 25 159 Funding Number: PAR 25 159 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Prevention and Alcohol (R01 Clinical Trials Optional) Apply for PAS 25 208 Funding Number: PAS 25 208 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Prevention and Alcohol (R34 Clinical Trials Optional) Apply for PAS 25 161 Funding Number: PAS 25 161 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required) Apply for PAR 25 288 Funding Number: PAR 25 288 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) Apply for PAR 25 177 Funding Number: PAR 25 177 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) Apply for PAR 25 179 Funding Number: PAR 25 179 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 274", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
